These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 18160603)

  • 41. Inherited thrombophilia: treatment during pregnancy.
    De Carolis S; Ferrazzani S; De Stefano V; Garofalo S; Fatigante G; Rossi E; Leone G; Caruso A
    Fetal Diagn Ther; 2006; 21(3):281-6. PubMed ID: 16601339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of low-molecular-weight and unfractionated heparin on trophoblast function.
    Quenby S; Mountfield S; Cartwright JE; Whitley GS; Vince G
    Obstet Gynecol; 2004 Aug; 104(2):354-61. PubMed ID: 15292011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of low-molecular-weight heparins in pregnancy--how safe are they?
    Deruelle P; Coulon C
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):573-7. PubMed ID: 18007136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome.
    Aracic N; Roje D; Drmic Hofman I; Capkun V; Stefanovic V
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):306-10. PubMed ID: 24749801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro evidences of heparin's effects on embryo implantation and trophoblast development.
    Tersigni C; Marana R; Santamarìa A; Castellani R; Scambia G; Simone ND
    Reprod Sci; 2012 May; 19(5):454-62. PubMed ID: 22378860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of low molecular weight heparin in women with recurrent pregnancy loss].
    Todorova K; Ivanov S
    Akush Ginekol (Sofiia); 2004; 43 Suppl 4():31-6. PubMed ID: 15673011
    [No Abstract]   [Full Text] [Related]  

  • 47. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of unfractionated heparin and low molecular weight heparins in pregnancy.
    Casele HL
    Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of anti-thrombotic therapy for recurrent pregnancy loss due to anti-phospholipid syndrome.
    Fawad S
    J Ayub Med Coll Abbottabad; 2010; 22(3):197-200. PubMed ID: 22338455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants.
    Grandone E; De Stefano V; Rossi E; Cappucci F; Colaizzo D; Margaglione M
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):226-30. PubMed ID: 18388503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment and management of high-risk pregnancies in women with thrombophilia.
    Sarig G; Vidergor G; Brenner B
    Blood Rev; 2009 Jul; 23(4):143-7. PubMed ID: 19135285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testing for inherited thrombophilia in recurrent miscarriage.
    de Jong PG; Goddijn M; Middeldorp S
    Semin Reprod Med; 2011 Nov; 29(6):540-7. PubMed ID: 22161466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?
    Kalk JJ; Huisjes AJ; de Groot CJ; van Beek E; van Pampus MG; Spaanderman ME; van Eyck J; Oei SG; Bezemer PD; de Vries JI
    Neth J Med; 2004 Mar; 62(3):83-7. PubMed ID: 15209472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias.
    Kupferminc MJ; Fait G; Many A; Lessing JB; Yair D; Bar-Am A; Eldor A
    Hypertens Pregnancy; 2001; 20(1):35-44. PubMed ID: 12044312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-molecular-weight heparin in pediatric patients.
    Sutor AH; Chan AK; Massicotte P
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():31-9. PubMed ID: 15085464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombophilia and fetal loss.
    Brenner B
    Semin Thromb Hemost; 2003 Apr; 29(2):165-70. PubMed ID: 12709919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
    Neikova K ; Dimitrova V; Dimitrov R; Savov A
    Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perinatal aspects of inherited thrombophilia.
    Bonnar J; Green R; Norris L
    Semin Thromb Hemost; 1999; 25(5):481-5. PubMed ID: 10625206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inherited thrombophilia and pregnancy: the obstetric perspective.
    Bonnar J; Green R; Norris L
    Semin Thromb Hemost; 1998; 24 Suppl 1():49-53. PubMed ID: 9840692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention and treatment of venous thromboembolism in pregnancy.
    James AH
    Clin Obstet Gynecol; 2012 Sep; 55(3):774-87. PubMed ID: 22828110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.